GWM
ATOS icon

Geneos Wealth Management’s Atossa Therapeutics ATOS Stock Holding History

Geneos Wealth Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-67
Closed -$1K – 2036
2022
Q2 		$1K Hold
67
– – ﹤0.01% 2464
2022
Q1 		$1K Hold
67
– – ﹤0.01% 2610
2021
Q4 		$1K Hold
67
– – ﹤0.01% 2643
2021
Q3 		$3K Sell
67
-200
-75% -$11.6K ﹤0.01% 2555
2021
Q2 		$21K Buy
267
+67
+34% +$3.55K ﹤0.01% 1888
2021
Q1 		$6K Hold
200
– – ﹤0.01% 2577
2020
Q4 		$6K Buy
+200
New +$4.63K ﹤0.01% 2399

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return